scPharmaceuticals Inc (SCPH)
4.65
-0.02
(-0.43%)
USD |
NASDAQ |
May 03, 16:00
4.65
0.00 (0.00%)
After-Hours: 20:00
scPharmaceuticals Debt to Equity Ratio: 1.043 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.043 |
| September 30, 2023 | 0.7785 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.595 |
| March 31, 2023 | 0.4914 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.4914
Minimum
Mar 2023
1.043
Maximum
Dec 2023
0.7269
Average
0.6867
Median
Debt to Equity Ratio Benchmarks
| Anika Therapeutics Inc | 0.00 |
| Spero Therapeutics Inc | 0.00 |
| electroCore Inc | 0.00 |
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 94.48M |
| Total Liabilities (Quarterly) | 57.26M |
| Shareholders Equity (Quarterly) | 37.22M |
| Current Ratio | 7.076 |
| Net Debt Paydown Yield | -0.12% |